Cancer researchers are working to improve their understanding of who will benefit from powerful immunotherapies
Cancer researchers and drugmakers are beginning to broaden the benefits of so-calledby zeroing in on patient or tumor characteristics to better predict who might respond to the powerful treatments.
In research presented at a major scientific meeting this week, oncologists made early but promising inroads into various cancers with immunotherapy drugs from GSK PLC, Bristol-Myers Squibb Co. and others that harness the power of the immune system to fight cancer with generally fewer side effects than other therapies.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Hoggard case highlights need for clarity on reforms to sex assault trials: expertsExperts say the trial of Canadian musician Jacob Hoggard has highlighted the need for clarity on how to navigate legal changes meant to protect the privacy of…
Read more »
A new rectal cancer treatment eliminated all tumors in a small group of patientsThe experimental drug, dostarlimab, swiftly shrank the tumors in 12 patients with rectal cancer, surprising authors of a new study.
Read more »
Son Of Buffalo Victim Implores Congress To Act Against 'Cancer Of White Supremacy'Families of victims and survivors of the mass shootings in Buffalo and Uvalde travelled to Capitol Hill to testify to the human toll of U.S. gun violence this week.
Read more »
Every patient in this experimental drug trial saw their cancer disappear, researchers sayA small clinical trial conducted by Memorial Sloan Kettering Cancer Center found that every single rectal cancer patient who received an experimental immunotherapy treatment had their cancer go into remission.
Read more »
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer - NatureThe lineage transcription factor PAX8 is shown to play a pivotal part in determining cancer risk in clear cell renal cell carcinoma, providing insights into how genetic mutations lead to specific types of cancer.
Read more »
Mutation and tissue lineage lead to organ-specific cancerTranscription factor provides clue to why cancer arises in kidney cells.
Read more »